ABBVIE INC.
ABBV XNYS
$256.46
-3.68 (-1.41%)
▼
15-min delayed
Open
$257.96
High
$258.91
Low
$255.58
Volume
4.73M
Market Cap
$453.19B
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $16.99B | $3.62B | $2.04 |
| Q1 2026 | $15.00B | $697.00M | $0.39 |
| FY 2025 | $61.16B | $4.23B | $2.37 |
| Q3 2025 | $15.78B | $188.00M | $0.10 |
TickerDaily Coverage
Healthcare Stocks This Week: XLV Gains 2.1% as UNH, LLY Lead Sector Rally (Aug 3–7, 2026)
Market News
David Brooks · Aug 7, 2026
The healthcare sector finished the week with solid momentum, as the Health Care Select Sector SPDR...
Stock Market Today, July 19, 2026: Earnings Bonanza Looms — AMZN, AAPL, MSFT Lead Week
Market News
David Brooks · Jul 20, 2026
The stock market enters a pivotal earnings week starting Monday, July 27, with mega-cap tech titans...
Healthcare Stocks This Week: XLV Outperforms on Rate Cut Bets — Weekly Roundup (Jun 29 – Jul 3, 2026)
Market News
David Brooks · Jul 3, 2026
The healthcare sector capped a record-breaking first half with a strong week as XLV rallied on...
Healthcare Stocks This Week: XLV Outperforms Amid Pharma Strength (Jun 15–19, 2026)
Market News
David Brooks · Jun 19, 2026
The healthcare sector finished the week with measurable gains as large-cap pharma stocks and...
Healthcare Stocks This Week: XLV Underperforms Tech Rally Amid Inflation Concerns (Jun 1–5, 2026)
Market News
David Brooks · Jun 5, 2026
The healthcare sector underperformed the broader market during the week of June 1–5, 2026, with the...
View All Coverage →
Get ABBV Alerts
Stay ahead with breaking news, price alerts, and expert analysis on ABBVIE INC..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.